Table: Modalis Therapeutics - 6-MTH group results
Aug 14 (Reuters)-
Modalis Therapeutics Corporation
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2020 Jun 30, 2019 Dec 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 337 mln
Operating 38 mln
Recurring 29 mln
Net 26 mln
EPS 1.07 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Modalis Therapeutics Corporation.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T